Clinical Trials Browser

Phase 1 × Completed × Basal Cell Carcinoma of the Head and Neck × Clear all

NCT04323202 2025-10-24

Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N

Phase 1 Completed

DermatologicHead & Neck

Basal Cell Carcinoma of the Head and Neck